Literature DB >> 8431220

Appearance of anti-DNA antibodies in patients treated with interferon-alpha.

M R Ehrenstein1, E McSweeney, M Swane, C P Worman, A H Goldstone, D A Isenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8431220     DOI： 10.1002/art.1780360224

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  11 in total

1.  Inhibition of a C-rich oligodeoxynucleotide on activation of immune cells in vitro and enhancement of antibody response in mice.

Authors:  Guang Yang; Min Wan; Yongsheng Zhang; Luguo Sun; Ran Sun; Dali Hu; Xiaojing Zhou; Li Wang; Xiuli Wu; Liying Wang; Yongli Yu
Journal:  Immunology       Date:  2010-12       Impact factor: 7.397

2.  Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions.

Authors:  L Farkas; K Beiske; F Lund-Johansen; P Brandtzaeg; F L Jahnsen
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  Reduced blood BDCA-2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus.

Authors:  K Migita; T Miyashita; Y Maeda; H Kimura; M Nakamura; H Yatsuhashi; H Ishibashi; K Eguchi
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

Review 4.  The role of cytokines in the immunopathogenesis of lupus.

Authors:  B S Handwerger; V Rus; L da Silva; C S Via
Journal:  Springer Semin Immunopathol       Date:  1994

5.  Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells.

Authors:  H Travis Ichikawa; Thomas Conley; Tony Muchamuel; Jing Jiang; Susan Lee; Teresa Owen; Jennifer Barnard; Sarah Nevarez; Bruce I Goldman; Christopher J Kirk; R John Looney; Jennifer H Anolik
Journal:  Arthritis Rheum       Date:  2012-02

6.  Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus.

Authors:  Deanna M Santer; Taku Yoshio; Seiji Minota; Thomas Möller; Keith B Elkon
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

Review 7.  Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.

Authors:  Theophanis P Karageorgas; Dimitrios D Tseronis; Clio P Mavragani
Journal:  J Biomed Biotechnol       Date:  2011-11-16

8.  BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction.

Authors:  A Dzionek; Y Sohma; J Nagafune; M Cella; M Colonna; F Facchetti; G Günther; I Johnston; A Lanzavecchia; T Nagasaka; T Okada; W Vermi; G Winkels; T Yamamoto; M Zysk; Y Yamaguchi; J Schmitz
Journal:  J Exp Med       Date:  2001-12-17       Impact factor: 14.307

Review 9.  Mediators of inflammation and their effect on resident renal cells: implications in lupus nephritis.

Authors:  Susan Yung; Kwok Fan Cheung; Qing Zhang; Tak Mao Chan
Journal:  Clin Dev Immunol       Date:  2013-09-22

10.  Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus.

Authors:  Seung-Ki Kwok; June-Yong Lee; Se-Ho Park; Mi-La Cho; So-Youn Min; Sung-Hwan Park; Ho-Youn Kim; Young-Gyu Cho
Journal:  Arthritis Res Ther       Date:  2008-03-06       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.